Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
REGISTERED
on 15 Jan 2021
Last Applicant/ Owned by
NANOTICS LLC
531 Midvale Way Mill Valley , CA 94941
US
Serial Number
1874356 filed on 21st Dec 2017
Registration Number
TMA1091729 registered on 15th Jan 2021
Registration expiry Date
15th Jan 2031Correspondent Address
130 Queens Quay EastEast Tower, Suite 809Toronto,
ONTARIO
CA
M5A0P6
NANOT
Trademark usage description
pharmaceutical preparations for the treatment of substance addiction, diseases of ageing, namely loss of physical and mental function associated with Read MoreClassification Information
Class [005]
Pharmaceutical preparations for the treatment of substance addiction, diseases of ageing, namely loss of physical and mental function associated with ageing, age-related cognitive decline, dementia, musculoskeletal disease, senescence of bodily tissues, allergic rhinitis, Alzheimer's, ankylosing spondylitis, asthma, atherosclerosis, cancer, chronic fatigue syndrome (CVS), Crohn's disease, colitis / ulcerative, cardiovascular disease (CVD), dementia, depression, diabetes / T2, eczema / atopic (AE), Epstein-Barr virus (EBV), fungal Infections, Graft versus host disease (GVHD), Hodgkin's disease, idiopathic pulmonary fibrosis (IPF), bacterial infection, viral infection, leukemia, lupus, lymphoma, macular degeneration, malaria, Methicillin-resistant Staphylococcus aureus (MRSA), multiple sclerosis, myasthenia gravis, obesity, pain, parasites, pre-eclampsia, psoriasis, post-traumatic stress disorder (PTSD), renal disease, rheumatoid arthritis, sepsis, Sjogren's syndrome, transplant rejection, autoimmune diseases, Juvenile Idiopathic Arthritis, Cytokine Release Syndrome and osteoporosis; drug delivery agents in the form of nano-capsules and micro-capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
Classification kind code
11
Class [010]
Medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove aberrant cell signals circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove aberrant cell signals circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove aberrant cell signal inhibitors circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove aberrant cell signal inhibitors circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove metabolites circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove metabolites circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove antibodies circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove antibodies circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove enzymes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove enzymes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove toxins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove toxins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove vesicles circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove vesicles circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove exosomes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove exosomes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove drugs circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove drugs circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove allergens circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove allergens circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove proteins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove proteins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove peptides circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove peptides circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove nucleic acids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove nucleic acids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove lipids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove lipids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove carbohydrates circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove carbohydrates circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove sugars circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove sugars circulating in blood within the body to treat diseases
Classification kind code
11
Mark Details
Serial Number
1874356
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 26 on 18th Sep 2020 | Approved |
| Submitted for opposition 27 on 18th Sep 2020 | Approval Notice Sent |
| Submitted for opposition 15 on 29th Apr 2020 | Correspondence Created |
| Submitted for opposition 48 on 13th Mar 2020 | Agent Changed |
| Submitted for opposition 15 on 17th Oct 2019 | Correspondence Created |
| Submitted for opposition 22 on 14th Feb 2019 | Search Recorded |
| Submitted for opposition 20 on 14th Feb 2019 | Examiner's First Report |
| Submitted for opposition 31 on 27th Dec 2017 | Formalized |
| Submitted for opposition 1 on 22nd Dec 2017 | Created |
| Submitted for opposition 30 on 21st Dec 2017 | Filed |